ADVANCED TARGETING SYSTEMS, INC.

Basic Information

10451 Roselle St #300
SAN DIEGO, CA, 92121

http://www.ATSbio.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 010081909
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 9


  1. Targeting a Poor Prognosis Marker for Tumor Therapy

    Amount: $150,480.00

    DESCRIPTION (provided by applicant): Targeting a Poor Prognosis Marker for Tumor Therapy Summary The purpose of this proposal is to develop a medical treatment for the elimination of metastatic ca ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Selective Activation in Specific Neuronal Populations

    Amount: $99,175.00

    DESCRIPTION (provided by applicant): Selective Activation in Specific Neuronal Populations Summary: Molecules targeted towards cell surface markers have been used for years to identify specific cell t ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. Inhibition of Neurotransmission in Specific Neuronal Populations

    Amount: $114,336.00

    DESCRIPTION (provided by applicant): In extensive work over the last decade, it has become clear that biologically active molecules can be inserted into specific cell types through targeting to molec ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. Drug Development of a Chronic Pain Therapeutic

    Amount: $0.00

    DESCRIPTION (provided by applicant): SP-SAP, a conjugate between the peptide neurotransmitter substance P, and the ribosome-inactivating protein, saporin, has been shown, through previous NIH funding, ...

    SBIR Phase I 2003 Department of Health and Human Services
  5. Drug Development of a Chronic Pain Therapeutic

    Amount: $2,388,923.00

    DESCRIPTION (provided by applicant): SP-SAP, a conjugate between the peptide neurotransmitter substance P, and the ribosome-inactivating protein, saporin, has been shown, through previous NIH funding, ...

    SBIR Phase II 2003 Department of Health and Human Services
  6. Monoclonal Antibodies to Target Neuronal Populations

    Amount: $0.00

    N/A

    SBIR Phase I 2003 Department of Health and Human Services
  7. Monoclonal Antibodies to Target Neuronal Populations

    Amount: $798,353.00

    N/A

    SBIR Phase II 2003 Department of Health and Human Services
  8. Targeting Neurons Involved in Chronic Pain Transmission

    Amount: $133,547.00

    DESCRIPTION (Adapted from applicant's abstract): Chronic pain is an enormous problem in the United States: it is estimated that 30 to 100 million people suffer from it. Often, current ...

    SBIR Phase I 2001 Department of Health and Human Services
  9. TOXICOLOGY/SAFETY STUDIES OF A CHRONIC PAIN THERAPEUTIC

    Amount: $397,984.00

    N/A

    SBIR Phase II 2001 Department of Health and Human Services
  10. TOXICOLOGY/SAFETY STUDIES OF A CHRONIC PAIN THERAPEUTIC

    Amount: $0.00

    N/A

    SBIR Phase I 2001 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government